Haimen Pushi Pharmaceutical Co, based in Linjiang New District, Haimen, Nantong, East China’s Jiangsu province, will carry out a new respiratory pharmaceutical preparation project, according to an Aug 28 Haimen Daily report.

The project, which is expected to receive 120 million yuan ($16.74 million) in investment, will produce respiratory products and build a nebulized inhalation preparation line and respiratory delivery device production line.

After the completion of the project, around 60 million sets of aerosol inhalation preparations and 4.5 million sets of administration devices are expected to be produced every year. Annual output value is expected to reach 550 million yuan.

Technicians test products in a Haimen Pushi Pharmaceutical Co laboratory in Haimen, Nantong, East China’s Jiangsu province, Aug 27. [Photo/Haimen Daily]